TY  - GEN 
AU  - Olivera Salguero, Ruben
AU  - Blancas López-Barajas, María Isabel
PY  - 2023
UR  - https://hdl.handle.net/10481/82968
AB  - Background: Metastatic breast cancer (mBC) causes nearly all BC-related
deaths. Next-generation sequencing (NGS) technologies allow for the
application of personalized medicine using targeted therapies that could
improve patients’ outcomes....
LA  - eng
PB  - Frontiers
KW  - Molecular advisory board
KW  - Molecular tumor board
KW  - Metastatic breast cancer
KW  - Genomic data
KW  - Targeted therapy
KW  - Patient-centric trials
TI  - HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer
DO  - 10.3389/fonc.2023.1151496
ER  -